The goal of our study was to fill this gap by testing the hypothesis that KIF11 inhibition would serve to radiosensitize GBM by enriching the fraction of GBM cells within the radio-sensitive mitotic phase of the cell cycle. The gene discussed is KIF11; the disease is glioblastoma.